CLINICAL_TRIALS
trial_result
· 2022-11-18
Clinical Trial Update: JBT-101 in Systemic Lupus Erythematosus (SLE) [Phase 2]
Summary
Phase 2 trial of JBT-101 in systemic lupus erythematosus has been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Systemic Lupus Erythematosus, SLE | Phase 2 | Status: COMPLETED | Results posted: 2022-11-18